Chicago 2014 TFQO: Peter Meaney #COI 149 EVREV 1: Richard Aickin #COI 153 EVREV 1: Peter Meaney #COI 149 Taskforce: Pediatrics Resuscitation fluids (Peds)

Slides:



Advertisements
Similar presentations
Dallas 2015 TFQO: Allan de Caen COI#38 EVREV 1: Melissa Parker COI#259 EVREV 1: Takanari Ikeyama COI#235 Taskforce: Pediatrics Peds 820 : The use of fluids.
Advertisements

Journal Club Usha Niranjan PICU. Rationale 2 x cases of severe dehydration with metabolic acidosis –requesting for HDU management –as given 40mls/kg fluid.
Dallas 2015 TFQO: Myra Wyckoff #COI EVREV 1: Myra Wyckoff #COI EVREV 2: Lindsay Mildenhall #107 Taskforce: NRP NRP: 605 Two thumb verses two finger.
Dallas 2015 TFQO: Marya Strand, MD, MS; COI#222 EVREV 1: Marya Strand, MD, MS; COI#222 EVREV 1: Takahiro Sugiura, MD; COI#224 Taskforce: NLS Umbilical.
Dallas : CPAP and IPPV In spontaneously breathing preterm infants with respiratory distress requiring respiratory support in the delivery room,
Colloid versus Crystalloid in Hypovolemic Shock Controversy
Chicago 2014 TFQO: Kee-Chong Ng (#COI = 113) EVREV 1: Gene Ong (#COI = 118) EVREV 2: Jos Bruinenberg (#COI = 19) Taskforce: Pediatric Taskforce The Long.
Dallas 2015 TFQO: S. Velaphi COI #242 EVREVs: N. Singhal COI#213 H. Ersdal COI#76 Taskforce: Neonatal Maintaining Infant Temperature During Delivery Room.
Dallas 2015 TFQO: EVREVs: de Almeida, Maria Fernanda COI# Trevisanuto, Daniele COI# Taskforce: Neonatal Warming Adjunts #599 Among preterm neonates who.
Maitland K et al ,N Engl J Med 2011;364:
Dallas 2015 TFQO: David Stanton COI 328 EVREVs: Volker Wenzel COI 253& Emmanuelle Bourdon COI 333 Taskforce: BLS Passive ventilation techniques.
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI 261 EVREV 2: Daniel Pichel COI # 513 Taskforce: ACS ACS 335: Pre-hospital ADP- Receptor.
Dallas 2015 TFQO: Jerry Nolan #310 EVREV 1: Jerry Nolan COI #301 EVREV 2: Charles Deakin COI #221 Taskforce: ALS ALS 714 : Advanced airway placement (SGA.
Peds-818: Pediatric Early Warning Scores
Dallas 2015 TFQO: Vinay Nadkarni MD COI#249 EVREV 1: Graeme Maclaren MBBS COI#98 EVREV 2: Ravi Thiagarajan MBBS, MPH COI#149 Taskforce: PALS Peds 819 :
Dallas 2015 TFQO: Karen Woolfrey COI #261 EVREV 1: Karen Woolfrey COI #261 EVREV 2: Daniel Pichel COI #513 Taskforce: ACS ACS 873: Pre-hospital STEMI Activation.
Dallas 2015 TFQO: Jeffry Pearlman COI# 187 EVREV 1: Enrique Udaeta COI# 239 EVREV 1: Edgardo Ezslyd COI# 277 Taskforce: NRP Laryngeal Mask Airway (NRP.
Adherence to Sepsis Guidelines and Hospital Stay Elspeth Ferguson SCH Journal Club 6 th November 2012.
Dallas 2015 TFQO: EVREVs: Aaron Donoghue / Jonathan Duff Taskforce: EIT Teaching Compression-Only CPR.
Dallas 2015 TFQO: Masanori Tamura #147 EVREV 1: Masanori Tamura #147 EVREV 2: Susan Niermeyer #252 Delayed Cord Clamping in Preterm Infants Including those.
NRP: 862: Use of Feedback CPR Devices for Neonatal Cardiac Arrest NRP: 863: Use of Feedback CPR Devices to detect ROSC for Neonatal Cardiac Arrest TFQO:
Nicolai Haase, MD, PhD Department of Intensive Care Copenhagen University Hospital - Rigshospitalet Resuscitating sepsis – how I do it after 6S 4th International.
Dallas 2015 TFQO: Marilyn Escobedo COI#78 EVREV 1: Marilyn Escobedo COI#78 EVREV 2: Henry Lee COI#135 Taskforce: NRP Babies born to mothers who are hypothermic.
Dallas 2015 TFQO: Robert Greif EVREVs: Jan Breckwoldt, Henrik Fischer Taskforce: Education Implementation and Training (EIT) AED training methods.
Dallas 2015 TFQO: Enrique Udaeta COI# 239 EVREV 1: Enrique Udaeta COI# 239 EVREV 1: Edgardo Ezslyd COI# 277 Taskforce: NRP Laryngeal Mask Airway (NRP 618)
Dallas 2015 TFQO: EVREVs: Guinsburg, Ruth COI# McGowan, Jane COI# Taskforce: Neonatal Apgar Zero #896 In infants ≥36 weeks GA with an Apgar score.
Dallas 2015 TFQO: Name EVREV 1: Jonathan Wyllie COI #282 EVREV 1: Jeff Perlman COI #262 Taskforce: Newborn Temperature Maintenance in the Delivery room.
Chicago 2014 TFQO: Nikolaos Nikolaou COI#253 EVREV 1: Nikolaos Nikolaou COI#253 EVREV 2: Farzin BeyguiCOI#202 Taskforce: ACS STEMI transfer PCI vs. FL.
Chicago 2014 TFQO: Darren Walters COI #317 EVREV 1: Darren Walters COI #317 EVREV 2: Chris Ghaemmaghami COI #60 Taskforce: Acute Coronary Syndrome In STEMI.
Dallas 2015 TFQO: Anne-Marie Guerguerian # 97 EVREV1: Anne-Marie Guerguerian # 97 EVEREV2: Ericka Fink # 83 Taskforce: PEDS Peds 407 : ECMO for pediatric.
Dallas 2015 TFQO: Darren Walters EVREVs: EVREV 1: Darren Walters COI #422 EVREV 2: Chris Ghaemmaghami COI #89 Taskforce: Acute Coronary Syndrome Fibrinolytic.
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit The SAFE Study Investigators N Engl J Med 2004: 350:
First Aid 801: Stroke Recognition
Dallas 2015 TFQO: Name and #COI EVREV 1: Name and #COI Taskforce: Name Insert Short PICO title (including unique PICO ID#) Total of 4 (maximum) using standard.
Dallas 2015 TFQO: David Boyle COI #26 EVREV 1: David Boyle #COI#26 EVREV 1: Jane McGowan #370 Taskforce: Neonatal Ventilation Strategies in the DR (NRP.
Dallas 2015 TFQO: Name and #COI EVREV 1: Name and #COI Taskforce: Name Insert Short PICO title (including unique PICO ID#) Total of 6 (maximum) using standard.
Dallas 2015 TFQO: Michael Sayre COI #400 EVREV 1: Mohamud Daya COI #327 EVREV 2: Jan-Thorsten Gräsner COI #230 Taskforce: BLS BLS 363: CPR Prior to Defibrillation.
Chicago 2014 TFQO: Charles Deakin #329 EVREV 1: Asger Granfeldt COI #63 EVREV 2: Bo Lofgren COI #363 Taskforce: ALS ALS 571 : Ventilation strategy post-ROSC.
Dallas 2015 TFQO: Allan de Caen COI #38 EVREV 1: Tia Raymond COI #153; EVREV 2: Jonathan Egan COI #44 Taskforce: Peds The role of invasive vascular monitoring.
Dallas 2015 TFQO: Kee-Chong Ng (#COI = 170) EVREV 1: Gene Ong (#COI = 118) EVREV 2: Jos Bruinenberg (#COI = 19) Taskforce: Pediatric Taskforce The Long.
Dallas 2015 TFQO: Vinay Nadkarni #375 EVREV 1: Vinay Nadkarni #375 EVREV 1: Dave Kloeck #126 Taskforce: Paeds Paed 424: Vasopressors in Paediatric cardiac.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Intermittent vs Continuous Pulse Oximetry McCulloh R, Koster M, Ralston S, et al.
Chicago 2014 Pediatric RRT/MET Teams #397 TFQO: Dianne Atkins COI #7 EVREV 1: Dianne Atkins EVREV 2: Kee Chong Ng COI #113 Taskforce: Peds.
TFQO: Jasmeet Soar #COI 272 EVREV 1: Jasmeet Soar #COI 272 EVREV 2: Michael Donnino #COI 222 Taskforce: ALS ALS 448 OXYGEN DOSE AFTER ROSC IN ADULTS 3.
Dallas 2015 TFQO: Maaret Castrén #320 EVREV 1: Christian Vaillancourt #416 EVREV 2: Michael Sayre #400 Taskforce: BLS BLS 359: Dispatcher Instructions.
Dallas 2015 TFQO: Jan Jensen COI #115 EVREVs: Jan Jensen COI #115 Richard N. Bradley COI #151 Taskforce: First Aid 769: Hemostatic Dressings.
Dallas 2015 TFQO: Monica Kleinman COI #353 EVREV 1: Janice Tijssen COI#232 EVREV 2: Javier Urbano COI#240 Taskforce: Peds Peds 815: Pediatric goal-directed.
Dallas 2015 TFQO: Judith Finn EVREVs: Judith Finn #227 / Dion Stub #COI Taskforce: EIT Cardiac Arrest Centres.
Dallas 2015 TFQO: Michael W. Donnino COI# EVREVs: Katherine M. Berg COI# Lars W. Andersen COI# Taskforce: ALS Ultrasound During CPR.
Dallas 2015 TFQO: Jan Jensen COI #115 EVREV: Michael Reilly COI #193 Taskforce: First Aid First Aid 768: Use of Tourniquet.
Dallas 2015 TFQO: Koen Monsieurs 372 EVREV 1: Koen Monsieurs 372 EVREV 2: Ahamed Idris 349 Taskforce: BLS BLS366 Chest Compression Depth (adults)
Dallas 2015 TFQO: Jerry Nolan #310 EVREV 1: Jerry Nolan COI #301 EVREV 2: Jan-Thorsten Graesner COI #150 Taskforce: ALS ALS 783 : Advanced versus basic.
Dallas 2015 TFQO: Robert Greif EVREVs: Dana Edelson, COI #334 Robert Greif, COI #344 Taskforce: EIT EIT 645: Debriefing of resuscitation performance.
Dallas 2015 TFQO: Hiroshi Nonogi #254 EVREVs: Hiroshi Nonogi #254 Tony Scott #138 Taskforce: ACS Fibrinolytic and immediate PCI for STEMI 882.
Dallas 2015 TFQO: S. Velaphi EVREV 1: N. Singhal COI #213 EVREV 2: S. Velaphi COI #242 EVREV 3: H. Ersdal – COI # 76 Taskforce: NLS Prognosis: In newborn.
Dallas 2015 TFQO: Karen Woolfrey #COI 261 EVREV 1: Karen Woolfrey # COI 261 EVREV 2: Daniel Pichel #COI 513 Taskforce: ACS ACS 872: Pre-hospital Diversion.
Dallas 2015 TFQO: Name EVREVs: Names and #COI Taskforce: Name Insert Short PICO title Total of 12 (no studies) to 20 slides (maximum) using standard format.
Dallas 2015 TFQO: Jonathan Witt (COI #418) EVREVs: Steve Lin (COI #137), Thomas Pellis (COI #186) and Katie Dainty (COI #) Taskforce: ALS ALS 428 : Antiarrhythmic.
Chicago 2014 TFQO: Clifton Callaway # EVREV 1: Janice Zimmerman # EVREV 2: Jonathan Sullivan COI # Taskforce: ALS ALS 790 : Induced Hypothermia.
Towards Global Eminence K Y U N G H E E U N I V E R S I T Y j 내과 R2 이지영.
Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness Robert O. Opoka 1, Sarah Kiguli 1, Peter Olupot- Olupot.
Anything else? Glucose – tight control must be better NICE-SUGAR study investigators. Intensive versus conventional glucose control in critically ill.
Dallas 2015 TFQO: Jasmeet Soar #COI 409 EVREV 1: Jasmeet Soar #COI 409 EVREV 2: Anthony Lagina #COI 357 Taskforce: ALS ALS 889 OXYGEN DOSE DURING CPR IN.
Dallas 2015 TFQO: Michael Donnino #222 EVREV 1: Joshua Reynolds COI #265 EVREV 2: Katherine Berg COI #10 Taskforce: ALS ALS 790 : Induced Hypothermia.
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated May 26, 2017.
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated August 30, 2017.
Code Sepsis: Current Evidence Based Guidelines and the CMS Sepsis Core Measure Adult Patients - Abbreviated Updated August 30, 2017.
Sepsis Core Measure August 25, 2015.
The Conservative vs. Liberal Approach to fluid therapy of Septic Shock in Intensive Care CLASSIC Trial Tine Sylvest Meyhoff,
The Conservative vs. Liberal Approach to fluid therapy of Septic Shock in Intensive Care CLASSIC Trial Tine Sylvest Meyhoff,
Presentation transcript:

Chicago 2014 TFQO: Peter Meaney #COI 149 EVREV 1: Richard Aickin #COI 153 EVREV 1: Peter Meaney #COI 149 Taskforce: Pediatrics Resuscitation fluids (Peds) (Peds-545)

Chicago 2014 COI Disclosure (SPECIFIC to this systematic review) Richard Aickin #COI 3 Commercial/industry None Potential intellectual conflicts None Peter Meaney #COI 105 Commercial/industry None Potential intellectual conflicts None

Chicago Treatment Recommendation Topic not reviewed in PICO In infants and children with any type of shock (P), does the use of any specific resuscitation fluid or combination of fluids eg: isotonic crystalloid, colloid, hypertonic saline, blood products (I) when compared with standard care (C) improve patient outcome (hemodynamics, survival) (O)?

Chicago 2014 C2015 PICO Population: infants and children who are in septic shock in any setting Intervention: restricted volumes of isotonic crystalloid or non-crystalloid Comparison:20cc/kg boluses of isotonic crystalloid Outcomes: 9-CriticalSurvival to hospital discharge 8-CriticalComplications 8-CriticalNeed for mechanical ventilation or vasopressor support 7-CriticalTime to resolution of Shock 5-ImportantHospital length of stay 4-ImportantTotal IV fluids administered 4-ImportantVentilator free days

Chicago 2014 Inclusion/Exclusion & Articles Found Inclusions Human, infant/child, controlled trial or case series, septic shock (inc. malaria, dengue shock syndrome) Exclusions Adult only studies, other forms of shock (e.g. burns, trauma), no comparison with isotonic crystalloid bolus Number of Articles initially identified: 2657 Reviewed in full: Included in Evidence Profile tables 9 RCTs 2 non-RCTs 16 excluded (no comparison, adherence to protocol only, colloid-colloid, hypotonic, hypertonic, adult only, duplicate)

Chicago Proposed Treatment Recommendations Draft Treatment Recommendations: For infants and children we suggest against restricted fluids in comparison to 20mls/kg who have a Sepsis/Septic Shock (weak recommendation, very low quality of evidence), Malaria with severe anemia or moderate-severe acidosis (weak recommendation, low-moderate quality of evidence). There is no evidence regarding Dengue Shock Syndrome. For infants and children who have a febrile illness and some but not all signs of shock, we recommend for the use of restricted fluids as opposed to 20mls/kg boluses (weak recommendation, moderate quality of evidence).

Chicago Proposed Treatment Recommendations Draft Treatment Recommendations: For infants and children who have Sepsis/Septic Shock, Malaria with severe anemia or moderate-severe acidosis we recommend for the use crystalloid boluses over other fluid (weak recommendation, low to very low quality of evidence). For infants and children who have Dengue Shock Syndrome, we recommend for the use colloid as initial bolus over crytalloid (weak recommendation, moderate to low quality of evidence).

Chicago Proposed Treatment Recommendations Draft Treatment Recommendations: Regardless of etiology of shock, amount of fluid (rapid bolus or restricted fluids), or type of fluid, infants and children with some or all signs of shock should be prioritized for full assessment and treatment and reassessed within one hour.

Chicago 2014 Risk of Bias in studies RCT bias assessment StudyYearDesign Total Patients Population Industry Funding Allocation: Generation Allocation: Concealment Blinding: Participants Blinding: Assessors Outcome: Complete Outcome: Selective Other Bias First Author 2002RCT275OHCAPartlyLow HighLow Unclear First Author 2002RCT77OHCAUnclearHigh Low Unclear First Author 2005RCT16OHCAUnclearHigh UnclearLowHigh First Author 2012RCT36OHCANoLow HighLow Unclear First Author 2013RCT950OHCANoLow HighLow Non-RCT bias asssesment StudyYearDesign Total Patients Population Industry Funding Eligibility Criteria Exposure/Outcome Confounding Follow up First Author 2010 Non-RCT 828OHCAUnclearLow HighLow First Author 2011Non-RCT374OHCANoLow HighLow First Author 2011Non-RCT1,145OHCANoLow First Author 2011 Non-RCT 5,317OHCA/IHCANoHigh Low First Author 2012Non-RCT175OHCA/IHCANoUnclear HighLow First Author 2012Non-RCT100OHCA/IHCAUnclearLow HighLow First Author 2012Non-RCT118IHCAUnclearLow HighLow First Author 2013Non-RCT8,316IHCANoUnclearHigh Low Essential slide(s Please paste summary of bias assessments here (estimated time 30 sec). Ideally as one slide for both RCTs and non-RCTs (or two if necessary). Paste from excel spread sheet.

Chicago 2014 Evidence profile table(s)

Chicago 2014 Evidence profile table(s)

Chicago 2014 Evidence summary Colloid vs Crystalloid Fluid Bolus Therapy 3 high quality RCTs (Wills 2005 p877, Nhan 2001 p204, Dung 1999 p787) showed no differences between boluses of colloids and isotonic crystalloids in the treatment of Dengue Shock Syndrome (DSS) for the critical outcomes of complications and time to resolution of shock. None of these studies included a control group who received restricted fluid volumes. Mortality was low at 1.3% providing indirect support for fluid bolus therapy in Dengue SS. 1 retrospective review (very low quality) (Ranjit 2005 p412) of 20mls/kg ( ) vs 30mls/kg ( ) in the first hour for DSS suggested lower mortality for the more recent 30ml/kg bolus cohort.

Chicago 2014 Evidence summary Fluid Bolus Therapy in Severe Malaria Four RCTs investigated fluid bolus therapy for children with severe malaria and acidosis, comparing a variety of fluids (Gelofusine, HES, Albumin, Normal Saline, Ringers Lactate) and bolus volumes (10, 20, 40mls/kg). Outcomes included mortality and time to resolution of acidosis. Other than metabolic acidosis, signs of circulatory compromise were not used as inclusion/exclusion criteria A survival benefit is suggested for albumin vs alternative fluids. No restricted fluid controls were included. Akech 2006 e21, Akech , Maitland , Maitland

Chicago 2014 Evidence summary Fluid Bolus Therapy in Septic Shock (undifferentiated) Two RCTs compared different fluid bolus therapies in undifferentiated septic shock in children Santhanam mls/kg over 15mins vs 20-60mls/kg over 1 hr Goal directed Ringers lactate No difference in mortality (17.6%) or time to resolution of shock ICU level care

Chicago 2014 Evidence summary Fluid Bolus Therapy in Septic Shock (undifferentiated) Two RCTs compared different fluid bolus therapies in undifferentiated septic shock in children Chopra % saline 15ml/kg over 30 min vs normal saline mls/kg over 30min No differences in mortality, time to resolution of shock or duration of ICU stay.

Chicago 2014 Evidence summary Fluid Bolus Therapy in children with some but not all signs of shock One large high quality RCT compared boluses of mls/kg of 5%albumin vs normal saline vs no bolus in children with severe febrile illness and some but not all signs of shock. Outcome measures 48hr mortality Pulmonary edema, raised ICP 4weekmortality/neurological sequelae

Chicago 2014 Evidence summary FEAST Study 3141 children equal groups across 6 study centres in 3 African countries Stratified Stratum A impaired perfusion/fever: assigned to bolus or control Stratum B severe hypotension: assigned to one of 2 bolus groups Initial protocol changed to 40ml/kg in 1 st hr for stratum A and 60ml/kg for stratum B June 2010 No difference between albumin and saline bolus RR mortality bolus therapy 1.45 vs no bolus, absolute excess mortality 3.3%

Chicago 2014 Proposed Consensus on Science statements Summary statement: For the critical outcome of “mortality” we have identified high quality evidence from one RCT enrolling 3141 patients showing harm (OR % CI 1.13 – 1.86) from the use of fluid bolus therapy in African children with severe infection. We found weak evidence supporting the use of fluid bolus therapy for children in other settings.

Chicago 2014 Proposed Consensus on Science statements Summary statement: We did not identify any evidence to suggest a benefit for alternative types of fluid vs. isotonic crystalloids for fluid bolus therapy for children with septic, malaria or dengue shock in any setting against the following outcome measures. 9-CriticalSurvival to hospital discharge 8-CriticalComplications 8-CriticalNeed for mechanical ventilation or vasopressor support 7-CriticalTime to resolution of Shock 5-ImportantHospital length of stay 4-ImportantTotal IV fluids administered 4-ImportantVentilator free days

Chicago 2014 Evidence summary Colloid vs Crystalloid Fluid Bolus Therapy 3 high quality RCTs (Wills 2005 p877, Nhan 2001 p204, Dung 1999 p787) showed no differences between boluses of colloids and isotonic crystalloids in the treatment of Dengue Shock Syndrome (DSS) for the critical outcomes of complications and time to resolution of shock. None of these studies included a control group who received restricted fluid volumes. Mortality was low at 1.3% providing indirect support for fluid bolus therapy in Dengue SS. 1 retrospective review (very low quality) (Ranjit 2005 p412) of 20mls/kg ( ) vs 30mls/kg ( ) in the first hour for DSS suggested lower mortality for the more recent 30ml/kg bolus cohort.

Chicago 2014 Evidence summary Fluid Bolus Therapy in Severe Malaria Four RCTs investigated fluid bolus therapy for children with severe malaria and acidosis, comparing a variety of fluids (Gelofusine, HES, Albumin, Normal Saline, Ringers Lactate) and bolus volumes (10, 20, 40mls/kg). Outcomes included mortality and time to resolution of acidosis. Other than metabolic acidosis, signs of circulatory compromise were not used as inclusion/exclusion criteria A survival benefit is suggested for albumin vs alternative fluids. No restricted fluid controls were included. Akech 2006 e21, Akech , Maitland , Maitland

Chicago 2014 Evidence summary Fluid Bolus Therapy in Septic Shock (undifferentiated) Two RCTs compared different fluid bolus therapies in undifferentiated septic shock in children Santhanam mls/kg over 15mins vs 20-60mls/kg over 1 hr Goal directed Ringers lactate No difference in mortality (17.6%) or time to resolution of shock ICU level care

Chicago 2014 Knowledge Gaps *DO NOT USE FOR PLENARY* - BREAKOUT ONLY (eg. ETT vs BVM) Other specific systematic review that would be helpful Relationship with training to ETT success Specific research required Adult ETT vs BVM Slide for Task Force Breakout Presentations Only (one slide only). Estimated time <30 sec